Continuing Conversations With the Speakers

Continuing Conversations With the Speakers sessions offer additional informal and interactive discussions to supplement the traditional didactic Q&A format of Scientific Program sessions.

These sessions are available on a first-come, first-served basis and are intended to give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those fields. Attendees should come prepared to actively participate in the discussions.

Continuing Conversations With the Speakers on Chromatin Structure in Development and Disease

Sunday, December 8, 2019, 11:15 a.m. - 12:15 p.m.
Orange County Convention Center, W232A, Level 2

Join Drs. Cigall Kadoch, Elisa Oricchio, and Erez Lieberman Aiden to continue the discussion of cutting-edge genomic techniques. The session will foster greater understanding of the three-dimensional state of the genome and highlight the importance of genome organization and nuclear architecture in normal hematopoiesis and malignancy. This session complements the Scientific Program session “Chromatin Structure in Development and Disease” and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Chair:

Kathrin M. Bernt, MD
Children's Hospital of Philadelphia
Philadelphia, PA

Speakers:

Gerd A. Blobel, MD, PhD
University of Pennsylvania
Philadelphia, PA

Elisa Oricchio, DPhil
Ecole Polytechnique Federale de Lausanne
Lausanne, Switzerland

Erez Lieberman Aiden, PhD
Baylor College of Medicine
Houston, TX

Continuing Conversations With the Speakers on Ex Vivo Bioengineering of Blood Products for Transfusion

Sunday, December 8, 2019, 11:15 a.m. - 12:15 p.m.
Orange County Convention Center, W231C, Level 2

Join Drs. Allan Doctor, Jan Frayne, and Koji Eto to further discuss recent developments in the manufacturing of bioengineered blood products, including novel blood substitutes and culture conditions needed to grow red blood and platelets from stem cells or immortalized cell lines. This session complements the Scientific Program session “Ex Vivo Bioengineering of Blood Products for Transfusion” and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Chair:

Karina Yazdanbakhsh, PhD
New York Blood Center
New York, NY

Speakers:

Allan Doctor, MD
University of Maryland School of Medicine
Baltimore, MD

Koji Eto, MD
Kyoto University
Kyoto, Japan

Jan Frayne, BSc, PhD
University of Bristol
Bristol, United Kingdom

Continuing Conversations With the Speakers on Genome Editing for Transplantation and Cellular Therapies

Saturday, December 7, 2019, 11:15 a.m. - 12:15 p.m.
Orange County Convention Center, W231C, Level 2

Join Drs. Feng Zhang, Giuliana Ferrari, and Wendell Lim to continue discussion of the basic biology of genome editing, approaches to incorporate such editing into transplant and other cellular therapy settings, and efforts to utilize editing techniques to create new methods that can enhance the efficacy and safety of cellular therapies. This session complements the Scientific Program session “Genome Editing for Transplantation and Cellular Therapies” and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Co-Chairs:

Catherine J. Wu, MD
Dana-Farber Cancer Institute
Boston, MA

Alan M. Hanash, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Speakers:

Giuliana Ferrari, PhD
Istituto Scientifico H. San Raffaele
Milan, Italy

Feng Zhang, PhD
The Broad Institute
Cambridge, MA

Wendell Lim, PhD
University of California-San Francisco
San Francisco, CA

Continuing Conversations With the Speakers on Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches

Saturday, December 7, 2019, 11:30 a.m. - 12:30 p.m.
Orange County Convention Center, W232A, Level 2

Join Drs. Dan Landau, Nancy Speck, Ido Amit, and Adam Mead to further discuss cutting-edge applications of single cell analyses to understand hematopoietic stem cell origin, the overall immune system, and cancer evolution. This session complements the joint Scientific Program session “Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches.” The session provides an increased opportunity for scientific peers to form collaborations and partnerships.

Co-Chairs:

James Palis, MD
University of Rochester Medical Center
Rochester, NY

Peter Valk
Erasmus University Medical Center
Rotterdam, Netherlands

Speakers:

Dan A. Landau, MD
New York Genome Center
New York, NY

Adam J. Mead, MD, PhD
University of Oxford
Oxford, United Kingdom

Ido Amit, PhD
Weizmann Institute of Science
Rehovot, Israel

Nancy Speck, PhD
University of Pennsylvania
Philadelphia, PA